Advertisement

Topics

Lek Ljubljana Holding GmbH Company Profile

09:47 EST 17th December 2018 | BioPortfolio

Lek, a Sandoz company, is one of the pillars of leading world generics company Sandoz. It operates as a global development center for products and technologies, as a global manufacturing center for active pharmaceutical ingredients and medicines, as a competence center for the development of vertically integrated products, as a Sandoz competence center in the field of development and manufacturing of biopharmaceutical products and as a supply center for the markets of CEE, SEE and CIS, sales Slovenia and sales services for Sandoz's global markets. Lek d.d. employs about 2,850 people and achieved total sales of USD 656,5 million in 2005.
Sandoz, a Division of the Novartis group, is a global leader in the field of generic pharmaceuticals, offering a wide array of high-quality, affordable products that are no longer protected by patents. Sandoz has a portfolio of more than 600 active substances in over 5 000 forms worldwide. Key product groups include antibiotics, treatments for central nervous system disorders, gastrointestinal medicines, cardiovascular treatments and hormone therapies. Sandoz develops, produces and markets these drugs along with pharmaceutical and biotechnological active substances and anti-infectives. In addition to the strong organic growth in recent years, Sandoz has made a series of acquisitions including Lek (Slovenia), Sabex (Canada), Hexal (Germany) and EonLabs (U.S.) and sells its products in more than 110 countries. In 2005, Sandoz employed around 20,000 people worldwide and posted sales of USD 4.7 billion

Location

Lek Moskva Representative Office Starokonjusenij per. 10/10 build. 1
Moscow
119002
Russia

Contact

Phone: 386 1 580 2111
Fax: 386 1 568 3517
Email: info.lek@sandoz.com


News Articles [435 Associated News Articles listed on BioPortfolio]

Laufende Fusionskontrollverfahren: DocMorris Holding GmbH, Berlin (D); Erwerb von Vermögenswerten, dem apo-rot Versandhandel, der Apotheke am Rothenbaum Birgit Dumke e.K, Hamburg (D);

Datum der Anmeldung:05.06.2018Aktenzeichen:B3-89/18Unternehmen:DocMorris Holding GmbH, Berlin (D); Erwerb von Vermögenswerten, dem apo-rot Versandhandel, der Apotheke am Rothenbaum Birgit Dumke e.K.....

Global BIPV Modules Market Status and Outlook 20182025 [Report Updated: 16082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynam...

New financing round at oncgnostics GmbH close

The life sciences company oncgnostics GmbH was able to double its investment of 750,000 euros following the very rapid and successful completion of its second crowd investing campaign on Seedmatch. A...

Cantabio Pharmaceuticals to Present Positive in vivo Efficacy Results in a Mice Model of Parkinson’s disease of One of Its Orally Administered Novel DJ-1 Protein Targeting Therapeutic Candidates at the XXV International Symposium on Medicinal Chemistry

SAN FRANCISCO, July 31, 2018 (GLOBE NEWSWIRE) -- Cantabio Pharmaceuticals Inc. (OTCQB:CTBO), a biopharmaceutical company developing novel disease modifying therapies for Alzheimer's (AD), Parkinso...

Royalties under patent licence agreements: can they remain payable even if the licensed patents(s) are revoked or not practised? Lessons from Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH

Précis In its recent decision in Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH (7 July 2016), the Court of Justice of the EU (“CJEU”) has ruled that an obligati...

Life science-veteran ny vd för UU holding

Gunilla Lundmark tillträder som ny vd för Uppsala universitets holdingbolag, UU holding.

Laufende Fusionskontrollverfahren: Bruker Daltonik GmbH, Bremen (D); Erwerb einer Mehrheitsbeteiligung von 80% an der HAIN LIFESCIENCE GmbH, Nehren (D);

Datum der Anmeldung:28.08.2018Aktenzeichen:B3-128/18Unternehmen:Bruker Daltonik GmbH, Bremen (D); Erwerb einer Mehrheitsbeteiligung von 80% an der HAIN LIFESCIENCE GmbH, Nehren (D);Produktmärkte:in.....

DGAP-Adhoc: Dermapharm Holding SE: Vertragsunterzeichnung zur Übernahme der EUROMED S.A. (deutsch)

Dermapharm Holding SE: Vertragsunterzeichnung zur Übernahme der EUROMED S.A. DGAP-Ad-hoc: Dermapharm Holding SE / Schlagwort(e): Fusionen & Übernahmen Dermapharm Holding SE: Vertragsunterzeichnung ....

PubMed Articles [81 Associated PubMed Articles listed on BioPortfolio]

Iron deficiency and cyanotic breath-holding spells: The effectiveness of iron therapy.

Frequent cyanotic breath holding spells cause fear and severe anxiety to parents. This study aimed to evaluate clinical, laboratory and treatment characteristics of children with cyanotic breath holdi...

EuroPrevent 2018: Report from the European Congress on Preventive Cardiology 19-21 April, 2018, in Ljubljana, Slovenia.

Evaluation of Skeletal and Dental Effects of Lower Lingual Arches.

A lower lingual arch is usually recommended as a holding device to maintain arch length and to prevent mesial migration of the mandibular first molars. Despite its widespread use, comparatively little...

Lamivudine monotherapy as a holding regimen for HIV-positive children.

In resource-limited settings holding regimens, such as lamivudine monotherapy (LM), are used to manage HIV-positive children failing combination antiretroviral therapy (cART) to mitigate the risk of d...

Motor experience with a sport-specific implement affects motor imagery.

The present study tested whether sport-specific implements facilitate motor imagery, whereas nonspecific implements disrupt motor imagery. We asked a group of basketball players (experts) and a group ...

Clinical Trials [137 Associated Clinical Trials listed on BioPortfolio]

Energy Cost for Holding a MedGem® Indirect Calorimeter

The goal of this clinical protocol is to perform a randomized crossover study to determine the energy cost of holding the MedGem® device above a person's normal resting metabolic rate (RM...

Kangaroo Holding Effects on Breast Milk

Kangaroo holding is a skin-to-skin method of holding a baby. Many research studies have investigated the maternal and infant benefits associated with kangaroo holding. The purpose of thi...

Kangaroo Holding and Maternal Stress

The primary objective is to determine if kangaroo holding in the first week after birth influences the stress levels of mothers who have delivered their infants prematurely and who require...

Holding, Stress and Bonding During Therapeutic Hypothermia Dyads During Therapeutic Hypothermia

Ten infants undergoing therapeutic hypothermia for hypoxic-ischemic encephalopathy will be enrolled in a new protocol that will allow mothers to hold their infants during the hypothermia t...

The Holding Area LINQ (Reveal LINQ Insertable Cardiac Monitor) Trial is a Prospective, Non-randomized, Single Center Post-market Clinical Trial

The Holding Area LINQ Trial is a clinical trial designed to compare the benefits in conducting impant procedures in the holding area of a hospital operating room vs cardiac catheterization...

Companies [799 Associated Companies listed on BioPortfolio]

OctreoPharm Sciences GmbH

OctreoPharm Sciences GmbH, located in Berlin (Germany) is a privately held clinical development company focusing on radiopharmaceuticals for the diagnosis and therapeutic control ...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

Aeroflex Holding Corp.

Aeroflex Holding Corp. is the holding company for Aeroflex Incorporated, a leading global provider of microelectronic components and test and measurement equipment used by compani...

Lek Ljubljana Holding GmbH

Lek, a Sandoz company, is one of the pillars of leading world generics company Sandoz. It operates as a global development center for products and technologies, as a global manufacturing center for ac...

Nexigen GmbH

"In April 2008 Nexigen closed an investment round involving Santo Holding (Strngmann) and 4SC AG. Nexigen currently employs 10 people and is located in Bonn, Germany."

More Information about "Lek Ljubljana Holding GmbH" on BioPortfolio

We have published hundreds of Lek Ljubljana Holding GmbH news stories on BioPortfolio along with dozens of Lek Ljubljana Holding GmbH Clinical Trials and PubMed Articles about Lek Ljubljana Holding GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Lek Ljubljana Holding GmbH Companies in our database. You can also find out about relevant Lek Ljubljana Holding GmbH Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record